This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Mark Your Calendar for Next Year's Event!
September 27-30, 2022Boston Convention and Exhibition Center

Cenk Sumen
Chief Technology Officer at Stemson Therapeutics


Cenk Sumen, PhD, is Chief Technology Officer of Stemson Therapeutics. He is a globally recognized expert in gene and cell therapy manufacturing and automation, working closely with cell therapy developers to support strategic consulting and clinical manufacturing while serving as a technical and business development leader in industry and teaching immunology to engineering students at NYU Tandon. Prior to joining Stemson, Cenk served as the Director of Business Development for the BioProduction Division at ThermoFisher. He currently serves in the Outreach & Communication (former Chair) and Publication Committees at ASGCT. Cenk earned his BS in Biology at MIT and his PhD in Microbiology & Immunology at Stanford University, completing post-doctoral studies in intravital imaging at Harvard Medical School and cancer immunology at Memorial Sloan-Kettering Cancer Center.

Agenda Sessions

  • ROOM 210A: iPSC Processes: Road to Automation and Closed System

  • ROOM 210B: PANEL: Let’s Settle the Debate – Can Auto and Allo Therapies Co-Exist